Successful Pharma Follows Unconventional Formula

Published: Nov 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Valeant Pharmaceuticals International Inc. is a complicated company – and a stock Canadian investors can no longer ignore. The Laval, Que.-based pharma company has had such a successful run under CEO Michael Pearson that it now has the 12th largest weighting on Canada’s benchmark S&P/TSX composite index, with a market capitalization of $38-billion.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news